Home > Boards > US Listed > Biotechs > Lineage Cell Therapeutics, Inc. (LCTX)

I am also wondering what's the news behind

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
 HonTer Member Profile
 
Followed By 1
Posts 51
Boards Moderated 0
Alias Born 03/02/17
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/12/2021 4:28:22 PM
Promising New OpRegen® Clinical Data Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D. Business Wire - 9/30/2021 10:52:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 9/28/2021 4:17:13 PM
Lineage to Present at the 2021 Cantor Virtual Global Healthcare Conference on September 27, 2021 Business Wire - 9/20/2021 8:00:00 AM
Data From Ongoing Clinical Trial Continues to Demonstrate a Single Administration of OpRegen® Can Provide Anatomical and Functional Improvements in Patients With Dry AMD With Geographic Atrophy Business Wire - 9/15/2021 9:00:00 AM
Opregen® Data Update Will Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, M.D. Business Wire - 9/13/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/2/2021 4:21:25 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/2/2021 4:16:55 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 9/2/2021 6:06:45 AM
Lineage Announces Appointment of General Counsel Business Wire - 9/1/2021 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/12/2021 4:22:53 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/12/2021 4:11:45 PM
Lineage Cell Therapeutics EPS beats by $0.01, misses on revenue Seeking Alpha - 8/12/2021 4:07:17 PM
Lineage Reports Second Quarter 2021 Financial Results and Highlights Additional Progress From Clinical Cell Therapy Programs Business Wire - 8/12/2021 4:05:00 PM
Lineage to Present at the H.C. Wainwright Ophthalmology Conference on August 17, 2021 Business Wire - 8/10/2021 8:00:00 AM
Lineage Cell Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on August 12, 2021 Business Wire - 8/5/2021 8:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 8/3/2021 5:01:40 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/21/2021 5:01:47 PM
OpRegen® Clinical Data Continues to Demonstrate Functional & Anatomical Improvements in Patients With Dry AMD With Geographi... Business Wire - 7/20/2021 8:00:00 AM
OpRegen® Data Update to Be Featured at 54th Annual Retina Society Meeting in Podium Presentation by Christopher D. Riemann, ... Business Wire - 7/13/2021 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:30:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:27:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:25:04 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:24:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 6:22:53 PM
HonTer   Tuesday, 01/29/19 12:33:13 PM
Re: ahab333 post# 1134
Post # of 1329 
I am also wondering what's the news behind the move...

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences